
Cell Description: Human
adenocarcinoma; ovary; ascites
Culture
medium: McCoy's
5a medium with sodium bicarbonate, 2mM L-glutamine, 1.0mM sodium pyruvate + 10%
fetal bovine serum. (Alternatively, DMEM:F-12 may be used)
Karyotype: (P16)
hypodiploid to hypotetraploid with dicentrics and large telocentric
AntigenExp: Blood
Type B; Rh+
Isoenzymes: PGM3,
1; PGM1, 1-2; ES-D, 1; Me-2, 1; AK-1, 1; GLO-1, 1-2; G6PD, B; Phenotype
Frequency Product: 0.0311
Tumorigenic: yes,
in nude mice; forms moderately well differentiated adenocarcinoma consistent
with ovarian primary
Depositor: Trempe
Sterility: Tests
for Mycoplasma, bacteria and fungi were negative
Biosafety Level: 1
Comments: Derived
from a 64 years old caucasian femal
ATCC
No.: HTB-77
Reference:
Fogh,
J. , ed., Human tumor cells in vitro. New York: Plenum Press; 1975:pp. 115-159.
Fogh J et al. Absence of HeLa cell contamination in 169 cell lines derived from
human tumors. J. Natl. Cancer Inst. 58: 209-214, 1977. J. Natl. Cancer Inst.
59: 221-226, 1977. Morimoto H et al. Overcoming tumor necrosis factor and drug
resistance of human tumor cell lines by combination treatment with anti-Fas
antibody and drugs or toxins. Cancer Res. 53: 2591-2596, 1993. Morimoto H et
al. Synergistic effect of tumor necrosis factor-alpha- and diphtheria toxin-
ediated cytotoxicity in sensitive and resistant human ovarian tumor cell lines.
J. Immunol. 147:2609-2616, 1991. Zhang X et al. Microfilament depletion and
circumvention of multiple drug resistance by sphinxolides. Cancer Res. 57:
3751-3758,1997. Clinton GM et al. Estrogens increase the expression of
fibulin-1, an extracellular matrix protein secreted by human ovarian cancer
cells. Proc. Natl. Acad. Sci. USA 93: 316-320, 1996. Zhang X and Smith CD.
Microtubule effects of welwistatin, a cyanobacterial indolinone that
circumvents multiple drug resistance. Mol. Pharmacol. 49: 288-294, 1996.